2025-05-09 18:36:37, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_002290 7355 bp mRNA linear PRI 28-MAY-2013 DEFINITION Homo sapiens laminin, alpha 4 (LAMA4), transcript variant 2, mRNA. ACCESSION NM_002290 VERSION NM_002290.4 GI:380503848 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 7355) AUTHORS Wang,Y., Fu,W., Xie,F., Wang,Y., Chu,X., Wang,H., Shen,M., Wang,Y., Wang,Y., Sun,W., Lei,R., Yang,L., Wu,H., Foo,J., Liu,J., Jin,L. and Huang,W. TITLE Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population JOURNAL J. Hum. Genet. 55 (8), 490-494 (2010) PUBMED 20485444 REMARK GeneRIF: Observational study of gene-disease association. (HuGE Navigator) REFERENCE 2 (bases 1 to 7355) AUTHORS Senyurek,I., Klein,G., Kalbacher,H., Deeg,M. and Schittek,B. TITLE Peptides derived from the human laminin alpha4 and alpha5 chains exhibit antimicrobial activity JOURNAL Peptides 31 (8), 1468-1472 (2010) PUBMED 20433883 REMARK GeneRIF: Data from experiment with peptide fragments suggest laminin alpha4 (and laminin alpha5) may be part of host defense response and may protect tissues from invading pathogens. REFERENCE 3 (bases 1 to 7355) AUTHORS Lugassy,C., Torres-Munoz,J.E., Kleinman,H.K., Ghanem,G., Vernon,S. and Barnhill,R.L. TITLE Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model JOURNAL J. Cutan. Pathol. 36 (12), 1237-1243 (2009) PUBMED 19469865 REMARK GeneRIF: LAMC2, LAMA4, ITGB1, ITGB3, RSPA and MMP2) are overexpressed in angiotropic melanoma cells vs. non-angiotropic melanoma cells from the same tumor REFERENCE 4 (bases 1 to 7355) AUTHORS Sprenger,C.C., Drivdahl,R.H., Woodke,L.B., Eyman,D., Reed,M.J., Carter,W.G. and Plymate,S.R. TITLE Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells JOURNAL Neoplasia 10 (12), 1350-1361 (2008) PUBMED 19048114 REMARK GeneRIF: LM alpha4 and beta2 have roles in in vitro migration and in vivo tumorigenicity of prostate cancer cells REFERENCE 5 (bases 1 to 7355) AUTHORS Xiao,S., Lux,M.L., Reeves,R., Hudson,T.J. and Fletcher,J.A. TITLE HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma JOURNAL Am. J. Pathol. 150 (3), 901-910 (1997) PUBMED 9060828 REFERENCE 6 (bases 1 to 7355) AUTHORS Richards,A., Al-Imara,L. and Pope,F.M. TITLE The complete cDNA sequence of laminin alpha 4 and its relationship to the other human laminin alpha chains JOURNAL Eur. J. Biochem. 238 (3), 813-821 (1996) PUBMED 8706685 REFERENCE 7 (bases 1 to 7355) AUTHORS Iivanainen,A., Sainio,K., Sariola,H. and Tryggvason,K. TITLE Primary structure and expression of a novel human laminin alpha 4 chain JOURNAL FEBS Lett. 365 (2-3), 183-188 (1995) PUBMED 7781776 REFERENCE 8 (bases 1 to 7355) AUTHORS Ryan,M.C., Tizard,R., VanDevanter,D.R. and Carter,W.G. TITLE Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair JOURNAL J. Biol. Chem. 269 (36), 22779-22787 (1994) PUBMED 8077230 REFERENCE 9 (bases 1 to 7355) AUTHORS Richards,A.J., al-Imara,L., Carter,N.P., Lloyd,J.C., Leversha,M.A. and Pope,F.M. TITLE Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain JOURNAL Genomics 22 (1), 237-239 (1994) PUBMED 7959779 REFERENCE 10 (bases 1 to 7355) AUTHORS Burgeson,R.E., Chiquet,M., Deutzmann,R., Ekblom,P., Engel,J., Kleinman,H., Martin,G.R., Meneguzzi,G., Paulsson,M., Sanes,J. et al. TITLE A new nomenclature for the laminins JOURNAL Matrix Biol. 14 (3), 209-211 (1994) PUBMED 7921537 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from BP234809.1, X91171.1, AB210027.1 and Z99289.1. On Mar 16, 2012 this sequence version replaced gi:157419121. Summary: Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]. Transcript Variant: This variant (2) uses an alternate in-frame splice site in the 5' coding region, compared to variant 1, resulting in a shorter protein (isoform 2), compared to isoform 1. Variants 2 and 3 encode the same isoform (2). Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: S78569.1, X91171.1 [ECO:0000332] RNAseq introns :: mixed/partial sample support ERS025081, ERS025082 [ECO:0000350] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-115 BP234809.1 1-115 116-1868 X91171.1 1-1753 1869-6154 AB210027.1 1742-6027 6155-7355 Z99289.1 50993-52193 c FEATURES Location/Qualifiers source 1..7355 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="6" /map="6q21" gene 1..7355 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="laminin, alpha 4" /db_xref="GeneID:3910" /db_xref="HGNC:6484" /db_xref="MIM:600133" exon 1..257 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 258..593 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" misc_feature 309..311 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="upstream in-frame stop codon" CDS 399..5849 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="isoform 2 precursor is encoded by transcript variant 2; laminin subunit alpha-4; laminin alpha 4 chain" /codon_start=1 /product="laminin subunit alpha-4 isoform 2 precursor" /protein_id="NP_002281.3" /db_xref="GI:380503849" /db_xref="CCDS:CCDS34514.1" /db_xref="GeneID:3910" /db_xref="HGNC:6484" /db_xref="MIM:600133" /translation="
MALSSAWRSVLPLWLLWSAACSRAASGDDNAFPFDIEGSSAVGRQDPPETSEPRVALGRLPPAAEKCNAGFFHTLSGECVPCDCNGNSNECLDGSGYCVHCQRNTTGEHCEKCLDGYIGDSIRGAPQFCQPCPCPLPHLANFAESCYRKNGAVRCICNENYAGPNCERCAPGYYGNPLLIGSTCKKCDCSGNSDPNLIFEDCDEVTGQCRNCLRNTTGFKCERCAPGYYGDARIAKNCAVCNCGGGPCDSVTGECLEEGFEPPTGCDKCVWDLTDDLRLAALSIEEGKSGVLSVSSGAAAHRHVNEINATIYLLKTKLSERENQYALRKIQINNAENTMKSLLSDVEELVEKENQASRKGQLVQKESMDTINHASQLVEQAHDMRDKIQEINNKMLYYGEEHELSPKEISEKLVLAQKMLEEIRSRQPFFTQRELVDEEADEAYELLSQAESWQRLHNETRTLFPVVLEQLDDYNAKLSDLQEALDQALNYVRDAEDMNRATAARQRDHEKQQERVREQMEVVNMSLSTSADSLTTPRLTLSELDDIIKNASGIYAEIDGAKSELQVKLSNLSNLSHDLVQEAIDHAQDLQQEANELSRKLHSSDMNGLVQKALDASNVYENIVNYVSEANETAEFALNTTDRIYDAVSGIDTQIIYHKDESENLLNQARELQAKAESSSDEAVADTSRRVGGALARKSALKTRLSDAVKQLQAAERGDAQQRLGQSRLITEEANRTTMEVQQATAPMANNLTNWSQNLQHFDSSAYNTAVNSARDAVRNLTEVVPQLLDQLRTVEQKRPASNVSASIQRIRELIAQTRSVASKIQVSMMFDGQSAVEVHSRTSMDDLKAFTSLSLYMKPPVKRPELTETADQFILYLGSKNAKKEYMGLAIKNDNLVYVYNLGTKDVEIPLDSKPVSSWPAYFSIVKIERVGKHGKVFLTVPSLSSTAEEKFIKKGEFSGDDSLLDLDPEDTVFYVGGVPSNFKLPTSLNLPGFVGCLELATLNNDVISLYNFKHIYNMDPSTSVPCARDKLAFTQSRAASYFFDGSGYAVVRDITRRGKFGQVTRFDIEVRTPADNGLILLMVNGSMFFRLEMRNGYLHVFYDFGFSGGPVHLEDTLKKAQINDAKYHEISIIYHNDKKMILVVDRRHVKSMDNEKMKIPFTDIYIGGAPPEILQSRALRAHLPLDINFRGCMKGFQFQKKDFNLLEQTETLGVGYGCPEDSLISRRAYFNGQSFIASIQKISFFDGFEGGFNFRTLQPNGLLFYYASGSDVFSISLDNGTVIMDVKGIKVQSVDKQYNDGLSHFVISSVSPTRYELIVDKSRVGSKNPTKGKIEQTQASEKKFYFGGSPISAQYANFTGCISNAYFTRVDRDVEVEDFQRYTEKVHTSLYECPIESSPLFLLHKKGKNLSKPKASQNKKGGKSKDAPSWDPVALKLPERNTPRNSHCHLSNSPRAIEHAYQYGGTANSRQEFEHLKGDFGAKSQFSIRLRTRSSHGMIFYVSDQEENDFMTLFLAHGRLVYMFNVGHKKLKIRSQEKYNDGLWHDVIFIRERSSGRLVIDGLRVLEESLPPTEATWKIKGPIYLGGVAPGKAVKNVQINSIYSFSGCLSNLQLNGASITSASQTFSVTPCFEGPMETGTYFSTEGGYVVLDESFNIGLKFEIAFEVRPRSSSGTLVHGHSVNGEYLNVHMKNGQVIVKVNNGIRDFSTSVTPKQSLCDGRWHRITVIRDSNVVQLDVDSEVNHVVGPLNPKPIDHREPVFVGGVPESLLTPRLAPSKPFTGCIRHFVIDGHPVSFSKAALVSGAVSINSCPAA
" sig_peptide 399..479 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="COORDINATES: ab initio prediction:SignalP:4.0" mat_peptide 480..5846 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /product="laminin subunit alpha-4 isoform 2" misc_feature 639..770 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin-type epidermal growth factor-like domain; laminins are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation; the laminin-type epidermal growth factor-like module occurs in...; Region: EGF_Lam; cd00055" /db_xref="CDD:28937" misc_feature 642..761 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin EGF-like (Domains III and V); Region: Laminin_EGF; pfam00053" /db_xref="CDD:200961" misc_feature order(642..644,648..650,669..671,690..692,699..701, 726..728) /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="EGF-like motif; other site" /db_xref="CDD:28937" misc_feature 810..950 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin EGF-like (Domains III and V); Region: Laminin_EGF; pfam00053" /db_xref="CDD:200961" misc_feature 816..953 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin-type epidermal growth factor-like domain; laminins are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation; the laminin-type epidermal growth factor-like module occurs in...; Region: EGF_Lam; cd00055" /db_xref="CDD:28937" misc_feature order(834..836,861..863,867..869,894..896) /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="EGF-like motif; other site" /db_xref="CDD:28937" misc_feature 957..1112 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin-type epidermal growth factor-like domain; laminins are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation; the laminin-type epidermal growth factor-like module occurs in...; Region: EGF_Lam; cd00055" /db_xref="CDD:28937" misc_feature 957..1097 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin EGF-like (Domains III and V); Region: Laminin_EGF; pfam00053" /db_xref="CDD:200961" misc_feature order(957..959,963..965,1002..1004,1023..1025,1032..1034, 1059..1061) /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="EGF-like motif; other site" /db_xref="CDD:28937" misc_feature 1299..2042 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin Domain I; Region: Laminin_I; pfam06008" /db_xref="CDD:191425" misc_feature 1392..1982 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Spectrin repeats, found in several proteins involved in cytoskeletal structure; family members include spectrin, alpha-actinin and dystrophin; the spectrin repeat forms a three helix bundle with the second helix interrupted by proline in some sequences; Region: SPEC; cd00176" /db_xref="CDD:29138" misc_feature 1665..1682 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="linker region; other site" /db_xref="CDD:29138" misc_feature 1698..2549 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Uncharacterized archaeal coiled-coil protein [Function unknown]; Region: COG1340" /db_xref="CDD:31531" misc_feature 2400..>2948 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="HlyD family secretion protein; Region: HlyD; pfam00529" /db_xref="CDD:109580" misc_feature 2577..2960 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin Domain II; Region: Laminin_II; pfam06009" /db_xref="CDD:203372" misc_feature 2880..3413 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin G domain; Laminin G-like domains are usually Ca++ mediated receptors that can have binding sites for steroids, beta1 integrins, heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins that contain LamG domains serve a variety of...; Region: LamG; cd00110" /db_xref="CDD:29010" misc_feature 3522..3998 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin G domain; Laminin G-like domains are usually Ca++ mediated receptors that can have binding sites for steroids, beta1 integrins, heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins that contain LamG domains serve a variety of...; Region: LamG; cd00110" /db_xref="CDD:29010" misc_feature 4086..4505 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin G domain; Laminin G-like domains are usually Ca++ mediated receptors that can have binding sites for steroids, beta1 integrins, heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins that contain LamG domains serve a variety of...; Region: LamG; cd00110" /db_xref="CDD:29010" misc_feature 4842..5249 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin G domain; Laminin G-like domains are usually Ca++ mediated receptors that can have binding sites for steroids, beta1 integrins, heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins that contain LamG domains serve a variety of...; Region: LamG; cd00110" /db_xref="CDD:29010" misc_feature 5322..5774 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /note="Laminin G domain; Laminin G-like domains are usually Ca++ mediated receptors that can have binding sites for steroids, beta1 integrins, heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins that contain LamG domains serve a variety of...; Region: LamG; cd00110" /db_xref="CDD:29010" variation 505 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:70940809" exon 594..695 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 678 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:35349917" exon 696..820 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 821..901 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 902..1116 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 1117..1191 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 1192..1343 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 1344..1454 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 1349 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="c" /db_xref="dbSNP:70940813" exon 1455..1566 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 1567..1734 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 1735..1928 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 1869 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:1050348" exon 1929..2045 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2046..2194 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2195..2336 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2337..2433 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2434..2550 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 2522 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:70940810" exon 2551..2730 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2731..2870 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 2871..3044 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 3032 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:35772073" exon 3045..3190 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 3187 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:35605307" exon 3191..3353 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 3354..3487 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 3488..3659 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 3660..3791 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 3733 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="g" /db_xref="dbSNP:1050349" exon 3792..3934 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 3935..4073 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 4074..4211 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 4212..4345 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 4320 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:70940811" exon 4346..4510 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 4442 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:34753919" exon 4511..4664 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 4550 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:35042032" exon 4665..4852 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 4853..5042 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 4935 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:34256052" exon 5043..5198 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 5093 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="c" /replace="t" /db_xref="dbSNP:35679345" exon 5199..5358 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 5359..5489 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 5490..5583 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" variation 5537 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="t" /db_xref="dbSNP:1050353" exon 5584..5703 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" exon 5704..7355 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /inference="alignment:Splign:1.39.8" STS 5819..5929 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /standard_name="D6S1133E" /db_xref="UniSTS:35049" variation 5820 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:3734292" variation 5896 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="g" /db_xref="dbSNP:11495" STS 5971..6097 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /standard_name="RH18133" /db_xref="UniSTS:76207" variation 6066 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /replace="a" /replace="t" /db_xref="dbSNP:1050447" polyA_signal 6131..6136 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" polyA_site 6157 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" STS 7188..7287 /gene="LAMA4" /gene_synonym="CMD1JJ; LAMA3; LAMA4*-1" /standard_name="A006N46" /db_xref="UniSTS:28608" ORIGIN
gaatattcttctggagcccttggaggggctccaaactgagaggggagggaagaccgcagggaaaggcggacctcagtgtctgaaaagccagcttagagtgggagggcctgggagtagaaggtaaaaagggagtggtgagaatgaatgtgagaaggaagccaggacagcgcagtccccagtcccgaacggccagggagaggaggtggcctagcgctggcggggctcaccccaatccgtctgccttttgatgccgtactctgctggttgcgcagccacctcgggatactgcacacggagaggagggaaaataagcgaggcaccgccgcaccacgcgggagacctacggagacccacagcgcccgagccctggaagagcactactggatgtcagcggagaaatggctttgagctcagcctggcgctcggttctgcctctgtggctcctctggagcgctgcctgctcccgcgccgcgtccggggacgacaacgcttttccttttgacattgaagggagctcagcggttggcaggcaagacccgcctgagacgagcgaaccccgcgtggctctgggacgcctgccgcctgcggccgagaaatgcaatgctggattctttcacaccctgtcgggagaatgtgtgccctgcgactgtaatggcaattccaacgagtgtttggacggctcaggatactgtgtgcactgccagcggaacacaacaggagagcactgtgaaaagtgtctggatggttatatcggagattccatcaggggagcaccccaattctgccagccgtgcccctgtcccctgccccacttggccaattttgcagaatcctgctataggaaaaatggagctgttcggtgcatttgtaacgaaaattatgctggacctaactgtgaaagatgtgctcccggttactatggaaaccccttactcattggaagcacctgtaagaaatgtgactgcagtggaaattcagatcccaacctgatctttgaagattgtgatgaagtcactggccagtgtaggaattgcttacgcaacaccaccggattcaagtgtgaacgttgcgctcctggctactatggggacgccaggatagccaagaactgtgcagtgtgcaactgcgggggaggcccatgtgacagtgtaaccggagaatgcttggaagaaggttttgaaccccctacaggctgtgataagtgcgtctgggacctgactgatgacctgcggttagcagcgctctccatcgaggaaggcaaatccggggtgctgagcgtatcctctggggccgccgctcataggcacgtgaatgaaatcaacgccaccatctacctcctcaaaacaaaattgtcagaaagagaaaaccaatacgccctaagaaagatacaaatcaacaatgctgagaacacgatgaaaagccttctgtctgacgtagaggaattagttgaaaaggaaaatcaagcctccagaaaaggacaacttgttcagaaggaaagcatggacaccattaaccacgcaagtcagctggtagagcaagcccatgatatgagggataaaatccaagagatcaacaacaagatgctctattatggggaagagcatgaacttagccccaaggaaatctctgagaagctggtgttggcccagaagatgcttgaagagattagaagccgtcaaccatttttcacccaacgggagctcgtggatgaggaggcagatgaggcttacgaactactgagccaggctgagagctggcagcggctgcacaatgagacccgcactctgtttcctgtcgtcctggagcagctggatgactacaatgctaagttgtcagatctccaggaagcacttgaccaggcccttaactatgtcagggatgccgaagacatgaacagggccacagcagccaggcagcgggaccatgagaaacaacaggaaagagtgagggaacaaatggaagtggtgaacatgtctctgagcacatctgcggactctctgacaacacctcgtctaactctttcagaacttgatgatataataaagaatgcgtcagggatttatgcagaaatagatggagccaaaagtgaactacaagtaaaactatctaacctaagtaacctcagccatgatttagtccaagaagctattgaccatgcacaggaccttcaacaagaagctaatgaattgagcaggaagttgcacagttcagatatgaacgggctggtacagaaggctttggatgcatcaaatgtctatgaaaatattgttaattatgttagtgaagccaatgaaacagcagaatttgctttgaacaccactgaccgaatttatgatgcggtgagtgggattgatactcaaatcatttaccataaagatgaaagtgagaacctcctcaatcaagccagagaactgcaagcaaaggcagagtctagcagtgatgaagcagtggctgacactagcaggcgtgtgggtggagccctagcaaggaaaagtgcccttaaaaccagactcagtgatgccgttaagcaactacaagcagcagagagaggggatgcccagcagcgcctggggcagtctagactgatcaccgaggaagccaacaggacgacgatggaggtgcagcaggccactgcccccatggccaacaatctaaccaactggtcacagaatcttcaacattttgactcttctgcttacaacactgcagtgaactctgctagggatgcagtaagaaatctgaccgaggttgtccctcagctcctggatcagcttcgtacggttgagcagaagcgacctgcaagcaacgtttctgccagcatccagaggatccgagagctcattgctcagaccagaagtgttgccagcaagatccaagtctccatgatgtttgatggccagtcagctgtggaagtgcactcgagaaccagtatggatgacttaaaggccttcacgtctctgagcctgtacatgaaaccccctgtgaagcggccggaactgaccgagactgcagatcagtttatcctgtacctcggaagcaaaaacgccaaaaaagagtatatgggtcttgcaatcaaaaatgataatctggtatacgtctataatttgggaactaaagatgtggagattcccctggactccaagcccgtcagttcctggcctgcttacttcagcattgtcaagattgaaagggtgggaaaacatggaaaggtgtttttaacagtcccgagtctaagtagcacagcagaggaaaagttcattaaaaagggggaattttcgggagatgactctctgctggacctggaccctgaggacacagtgttttatgttggtggagtgccttccaacttcaagctccctaccagcttaaacctgcctggctttgttggctgcctggaactggccactttgaataatgatgtgatcagcttgtacaactttaagcacatctataatatggacccctccacatcagtgccatgtgcccgagataagctggccttcactcagagtcgggctgccagttacttcttcgatggctccggttatgccgtggtgagagacatcacaaggagagggaaatttggtcaggtgactcgctttgacatagaagttcgaacaccagctgacaacggccttattctcctgatggtcaatggaagtatgtttttcagactggaaatgcgcaatggttacctacatgtgttctatgattttggattcagcggtggccctgtgcatcttgaagatacgttaaagaaagctcaaattaatgatgcaaaataccatgagatctcaatcatttaccacaatgataagaaaatgatcttggtagttgacagaaggcatgtcaagagcatggataatgaaaagatgaaaataccttttacagatatatacattggaggagctcctccagaaatcttacaatccagggccctcagagcacaccttcccctagatatcaacttcagaggatgcatgaagggcttccagttccaaaagaaggacttcaatttactggagcagacagaaaccctgggagttggttatggatgcccagaagactcacttatatctcgcagagcatatttcaatggacagagcttcattgcttcaattcagaaaatatctttctttgatggctttgaaggaggttttaatttccgaacattacaaccaaatgggttactattctattatgcttcagggtcagacgtgttctccatctcactggataatggtactgtcatcatggatgtaaagggaatcaaagttcagtcagtagataagcagtacaatgatgggctgtcccacttcgtcattagctctgtctcacccacaagatatgaactgatagtagataaaagcagagttgggagtaagaatcctaccaaagggaaaatagaacagacacaagcaagtgaaaagaagttttacttcggtggctcaccaatcagtgctcagtatgctaatttcactggctgcataagtaatgcctactttaccagggtggatagagatgtggaggttgaagatttccaacggtatactgaaaaggtccacacttctctttatgagtgtcccattgagtcttcaccattgtttctcctccataaaaaaggaaaaaatttatccaagcctaaagcaagtcagaataaaaagggagggaaaagtaaagatgcaccttcatgggatcctgttgctctgaaactcccagagcggaatactccaagaaactctcattgccacctttccaacagccctagagcaatagagcacgcctatcaatatggaggaacagccaacagccgccaagagtttgaacacttaaaaggagattttggtgccaaatctcagttttccattcgtctgagaactcgttcctcccatggcatgatcttctatgtctcagatcaagaagagaatgacttcatgactctatttttggcccatggccgcttggtttacatgtttaatgttggtcacaaaaaactgaagattagaagccaggagaaatacaatgatggcctgtggcatgatgtgatatttattcgagaaaggagcagtggccgactggtaattgatggtctccgagtcctagaagaaagtcttcctcctactgaagctacctggaaaatcaagggtcccatttatttgggaggtgtggctcctggaaaggctgtgaaaaatgttcagattaactccatctacagttttagtggctgtctcagcaatctccagctcaatggggcctccatcacctctgcttctcagacattcagtgtgaccccttgctttgaaggccccatggaaacaggaacttacttttcaacagaaggaggatacgtggttctagatgaatctttcaatattggattgaagtttgaaattgcatttgaagtccgtcccagaagcagttccggaaccctggtccacggccacagtgtcaatggggagtacctaaatgttcacatgaaaaatggacaggtcatagtgaaagtcaataatggcatcagagatttttccacctcagttacacccaagcagagtctctgtgatggcagatggcacagaattacagttattagagattctaatgtggttcagttggatgtggactctgaagtgaaccatgtggttggacccctgaatccaaaaccaattgatcacagggagcctgtgtttgttggaggtgttccagaatctctactgacaccacgcttggcccccagcaaacccttcacaggctgcatacgccactttgtgattgatggacacccagtgagcttcagtaaagcagccctggtcagcggcgccgtaagcatcaactcctgtccagcagcctgacatgacagagcacagctgcccaaatacaaagttctttagagcactgaaagaaacacaaagccagccaggaggaacagtaactcttccttcgggtggaagctttcatcgagttgaacaggacttaaacgaatcatcagggaccggatatttcttatttctcatttggattcttaaccttgaatccaaagtgtctgcaatggacaacaattgaaggagtggcaaacttacttgtattgagagcacacgcaattcctactggtgaaattactgtttctgtttctaataaaatagaagggattccaaataaacacttgcacacatttttgaagtgcggctagattctcagattcacctttcttccagggaagataactttcaatctatataaaaatctctgtcctaaaactacctttctttattttgaagagacttactaacttacatataatctaaattagatgatagatttgtttttagcccttttgtttggtctatcagtataagaagaatattttaggtttatagctgaagttatcaaggtttaataaagtaaatttctaacagaatactagaaaaatgcagtataatttaattttttctaaataagaaacacaggaaatcaactactttttccccttccttatctccttaaaagaaaaataaaattgtacatgagaggaggcttctgtaggttattattaccattattgtgtgttctatgggaatcattgaggatatcacagcaaaaacagtaggacaaaatcataaaattcaatttaagagtacacaagtccttttattaaaagtttgctcctagcctgggcaacataatgagatcccatctctgcaaaaaaatttgtacatgggcatacacctgtagtcccagctacttgggaggctgagacgggaggatcgcttaagctcaggagttcaaggctgcagtgagctatgactgctgactgtacctgcactccagcctgggcaacagagtgagatcctgtctcaaaaacaaagtgtgctctccacatacctgcaacacaactagtcttatttctaaaatgttataatcttttttccaagtagctacattaatatagtctagaaaaaaatggacttgaatagctggtagaatattaaaatatagaaatgaaataaaagaattatatctaaaaacctcaactcagaagacagaaaaagagaaaataggccctgatatcaacagaattaacaatacataaaaggagtaacttttgaggggagaggatataaaatattttgaggaattaccaaggggaataaaacaatgttaccttgaaatgattatatatatattacatattggtatatatgtccatacctacctatatcccctgctacccttctgtctgaaatatacaaataatgataatgttgaagatatcgataaacatagctaatgtctgttcatagaggacttactaagtgccagccaccatgataagctaaagttaattattttatttgttc
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:3910 -> Molecular function: GO:0005102 [receptor binding] evidence: IEA GeneID:3910 -> Molecular function: GO:0005201 [extracellular matrix structural constituent] evidence: TAS GeneID:3910 -> Biological process: GO:0001568 [blood vessel development] evidence: IEA GeneID:3910 -> Biological process: GO:0007155 [cell adhesion] evidence: IEA GeneID:3910 -> Biological process: GO:0030155 [regulation of cell adhesion] evidence: IEA GeneID:3910 -> Biological process: GO:0030198 [extracellular matrix organization] evidence: TAS GeneID:3910 -> Biological process: GO:0030334 [regulation of cell migration] evidence: IEA GeneID:3910 -> Biological process: GO:0045995 [regulation of embryonic development] evidence: IEA GeneID:3910 -> Biological process: GO:0050873 [brown fat cell differentiation] evidence: IEA GeneID:3910 -> Cellular component: GO:0005604 [basement membrane] evidence: IDA GeneID:3910 -> Cellular component: GO:0005605 [basal lamina] evidence: TAS GeneID:3910 -> Cellular component: GO:0005606 [laminin-1 complex] evidence: IEA GeneID:3910 -> Cellular component: GO:0031012 [extracellular matrix] evidence: ISS GeneID:3910 -> Cellular component: GO:0070062 [extracellular vesicular exosome] evidence: IDA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.